Byrnes Michael 4
4 · eFFECTOR Therapeutics, Inc. · Filed May 17, 2024
Insider Transaction Report
Form 4
Byrnes Michael
Chief Financial Officer
Transactions
- Award
Common Stock
2024-05-15$1.68/sh+1,387$2,334→ 3,117 total
Footnotes (1)
- [F1]These shares were acquired under the eFFECTOR Therapeutics, Inc. 2021 Employee Stock Purchase Plan.